Ingevity Corp
NGVT- Exchange
- NYSE
- Industry
- Chemicals & Allied Products
- SEC CIK
- 0001653477
In the last 90 days, Ingevity Corp insiders filed 0 open-market purchases and 2 sales; 318 institutions reported holding it in 13F filings for Q2 2026, worth $2.62B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 9, 2026
- $2.11B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $1.53M in total
- 2
- 13F holdersQ2 2026, +12 vs. previous quarter
- 318
- 13F valueReported value at the end of Q2 2026
- $2.62B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.17B
- −17.0% year over year
- Net income, FY2025
- -$167.1M
- No comparable prior period
- Free cash flow, FY2025
- $273.5M
- +436.3% year over year
- Revenue, Q3 FY2026
- $305.1M
- −8.4% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 1.36M
- Shares sold short
- Change
- −92.4K
- −6.4% vs. previous
- Days to cover
- 5.26
- At average daily volume
Superinvestors holding NGVT, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding NGVT at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Ingevity Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)5:14 PM ET | Aug 14-18 | 4 days | Li David HPresident & CEO | SSale | −10.1K | $75.77 | −$764.7K | −7.7%120.5K after | 3 lots10b5-1 |
| Aug 14, 2026 (view filing)5:06 PM ET | Aug 12-13 | 2 days | Li David HPresident & CEO | SSale | −10.0K | $76.18 | −$761.8K | −7.1%130.6K after | 2 lots10b5-1 |
| Aug 4, 2026 (view filing)5:14 PM ET | Aug 3 | 1 day | Fisher Ryan C.SVP, Gen. Counsel & Secretary | SSale | −2.71K | $73.72 | −$199.7K | −14.7%15.7K after | 2 lots |
| Jun 1, 2026 (view filing) | May 28 | 4 days | Dyer Terrance MSVP, Chief HR Officer | SSale | −496 | $68.49 | −$34.0K | −6.4%7.20K after | 3 lots |
| Mar 8, 2023 (view filing) | Mar 7 | 1 day | White Richard Allen JRSVP, Perf Chem and Pres, ISPT | SSale | −1.44K | $81.00 | −$116.6K | −18.1%6.53K after | |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Woodcock Stuart Edward Jr.EVP and Pres, Perf Materials | SSale | −4.97K | $82.14 | −$408.1K | −15.8%26.5K after | |
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Platt Phillip JohnCAO & VP, Bus Transform Lead | SSale | −8.85K | $81.71 | −$722.9K | −61.5%5.53K after | 4 lots |
| Dec 6, 2022 (view filing) | Dec 2 | 4 days | Ripple Erik SpencerChief Growth and Innovation Of | SSale | −856 | $77.84 | −$66.6K | −7.8%10.1K after | |
| Dec 5, 2022 (view filing) | Dec 1 | 4 days | White Richard Allen JRSVP, Perf Chem and Pres, ISPT | SSale | −1.64K | $77.97 | −$127.8K | −29.1%4.00K after | |
| Nov 10, 2021 (view filing) | Nov 8 | 2 days | Smith Michael P.EVP, President Perf Chemicals | SSale | −7.88K | $80.81 | −$636.6K | −25.9%22.5K after | 2 lots |
Top 10 13F holders, Q2 2026
See all 318 holdersThe largest institutional positions in Ingevity Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,364,204 | $400.5M | 0.01% | +66,489+1.3% | Added |
| Vanguard Portfolio Management LLC | 2,376,803 | $177.5M | 0.01% | +200,072+9.2% | Added |
| Vanguard Capital Management LLC | 1,571,127 | $117.3M | 0.00% | −10,744−0.7% | Reduced |
| State Street Corp | 1,497,321 | $111.8M | 0.00% | +38,086+2.6% | Added |
| American Century Companies Inc | 1,270,958 | $94.9M | 0.04% | −161,608−11.3% | Reduced |
| Wellington Management Group LLP | 1,075,514 | $80.3M | 0.01% | −418,778−28.0% | Reduced |
| Segall Bryant & Hamill, LLC | 1,054,605 | $78.7M | 0.93% | −54,443−4.9% | Reduced |
| Millennium Management LLC | 992,049 | $74.1M | 0.05% | −163,323−14.1% | Reduced |
| Brown Advisory Inc | 974,107 | $72.7M | 0.11% | −17,909−1.8% | Reduced |
| Royce & Associates LP | 940,417 | $70.2M | 0.57% | +56,890+6.4% | Added |
Holders of 5% or more of NGVT
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Ingevity Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.50%5.64M shares | – | Apr 30, 20251 filing | Apr 30, 2025 | SEC |
| Vanguard Portfolio Management LLC | 13G | 6.27%2.21M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.26%1.85M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |